Fenimore Christopher R.'s Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 29, 2024
- Accession no.
- 0001883850-24-000045
- Filed
- Aug 29, 2024
- Trade date
- Aug 28, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 10 non-derivative transactions. Open-market sales total $6.85M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fenimore Christopher R.CIK 0001697422 | Officer (SVP Finance & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | Common Stock | SSaleDisposed | −228 | $1,204.79F1 | −$274,692.12 | 966 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −766 | $1,205.44F2 | −$923,367.04 | 200 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −200 | $1,206.30F3 | −$241,260 | 0 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −2,237 | $1,204.71F4 | −$2,694,936.27 | 1,378 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −928 | $1,205.49F5 | −$1,118,694.72 | 450 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −450 | $1,206.15F6 | −$542,767.5 | 0 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −236 | $1,205.67F7 | −$284,538.12 | 225 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −200 | $1,206.70F8 | −$241,340 | 25 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −235 | $1,205.67F9 | −$283,332.45 | 225 | Indirect | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −200 | $1,206.67F10 | −$241,334 | 25 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.